Viewing nowCombinationJanudaprazole 10/100 milligrams
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.

MFDS item code 202200070 · Approved 2022.01.04 · Insurance code 653805990
Improvement of blood glucose control in type 2 diabetes mellitus
This medication helps improve blood sugar control more effectively while supporting dietary and exercise regimens for patients with type 2 diabetes. It is particularly suitable when taken in combination with sitagliptin and dapagliflozin, playing a crucial role in stabilizing blood glucose levels.
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. No dose adjustment is required when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. This medicine should not be administered when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication should not be used in cases of hypersensitivity. Severe allergic reactions or skin conditions may occur, so if any unusual symptoms appear, immediately discontinue use and consult a doctor. This medication may cause a severe pancreatic condition known as pancreatitis; therefore, if symptoms such as abdominal pain, vomiting, or loss of appetite occur after taking this medication, inform healthcare professionals immediately. This medication is not administered to patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. This medication must be used cautiously in patients with impaired kidney function or decreased fluid volume, and kidney function and blood pressure should be regularly monitored before and during administration. When used with other diabetic medications that pose a risk of hypoglycemia, symptoms of hypoglycemia may appear, so blood glucose changes should be closely monitored, and medication dosage adjusted as needed. Genital infections or urinary tract infections may occur, so immediate treatment is necessary if any infection symptoms appear. Elderly patients or patients with liver impairment may be more affected by this medication, requiring special caution during use. Pregnant or nursing women are advised not to use this medication, and if pregnancy is confirmed, they should immediately discontinue use. There is no specific antidote for overdose, so appropriate treatment should be administered based on symptoms, and monitoring in a hospital may be necessary as needed. This medication does not affect driving or operating machinery; however, caution is needed due to the risk of hypoglycemia when taken with other medications. Finally, this medication should be kept out of reach of children and stored in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C. This will help maintain its efficacy for a longer period.
Light yellow oblong film-coated tablet
Box - 28 tablets/box [(7 tablets/PTP (Alu-Alu) x 4)], Box - 30 tablets/box [(10 tablets/PTP (Alu-Alu) x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.